Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 6/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 1.00 |
| ▸ | SNCA | P37840 | 5/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 1.00 |
| ▸ | MAPT | P10636 | 4/20 | 1.00 |
| ▸ | PTGS1 | P23219 | 4/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 4/20 | 1.00 |
| ▸ | GAA | P10253 | 3/20 | 1.00 |
| ▸ | MEN1 | O00255 | 3/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 3/20 | 1.00 |
| ▸ | APEX1 | P27695 | 3/20 | 1.00 |
| ▸ | RECQL | P46063 | 3/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 3/20 | 1.00 |
| ▸ | PKM | P14618 | 2/20 | 1.00 |
| ▸ | ALPL | P05186 | 2/20 | 1.00 |
| ▸ | POLB | P06746 | 2/20 | 1.00 |
| ▸ | PTGS2 | P35354 | 2/20 | 1.00 |
| ▸ | RAD52 | P43351 | 2/20 | 1.00 |
| ▸ | HPGD | P15428 | 2/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Catechin SCHEMBL10001669 | 1.00 | BACE1 (1.00) | BACE1KDM4EHSD17B10SNCAALDH1A1 | |
| (+)-Epicatechin SCHEMBL862089 | 1.00 | BACE1 (1.00) | BACE1KDM4EHSD17B10SNCAALDH1A1 | |
| Cianidanol SCHEMBL1330653 | 1.00 | BACE1 (1.00) | BACE1KDM4EHSD17B10SNCAALDH1A1 | |
| Catechin SCHEMBL10033927 | 1.00 | BACE1 (1.00) | BACE1KDM4EHSD17B10SNCAALDH1A1 | |
| (-)-Epicatechin SCHEMBL19412 | 1.00 | BACE1 (1.00) | BACE1KDM4EHSD17B10SNCAALDH1A1 | |
| Cianidanol SCHEMBL12392372 | 1.00 | BACE1 (1.00) | BACE1KDM4EHSD17B10SNCAALDH1A1 | |
| Cianidanol SCHEMBL13610161 | 1.00 | BACE1 (1.00) | BACE1KDM4EHSD17B10SNCAALDH1A1 | |
| Catechin SCHEMBL19411 | 1.00 | BACE1 (1.00) | BACE1KDM4EHSD17B10SNCAALDH1A1 | |
| Cianidanol SCHEMBL19741 | 1.00 | BACE1 (1.00) | BACE1KDM4EHSD17B10SNCAALDH1A1 | |
| Cianidanol SCHEMBL5081456 | 1.00 | BACE1 (1.00) | BACE1KDM4EHSD17B10SNCAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1136 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4743071-A2 | DIPHENYLETHYLENE COMPOUNDS AND COMPOSITIONS THEREOF | INNOVENE INC. (US) | 2026-05-20 | — | — | EP | claimed |
| US-20260130395-A1 | Water Dispersible Botanical Compositions | AQUILA BLACK LTD (AU) | 2026-05-14 | — | — | US | claimed |
| EP-4739297-A1 | MODULATORS OF LYPOXYGENASES FOR TREATING CONDITIONS ASSOCIATED WITH CONE PHOTORECEPTOR DEGENERATION | SORBONNE UNIVERSITE (FR) | 2026-05-13 | — | — | EP | claimed |
| EP-4426105-B1 | COCOA PLANT CELL CULTURE PROCESSING METHODS AND PRODUCTS OBTAINED BY THE SAME | ZHAW ZUERCHER HOCHSCHULE FUER ANGEWANDTE WSS (CH) | 2026-04-29 | — | — | EP | claimed |
| US-20260103663-A1 | ANTIMICROBIAL MATERIALS AND NANOPARTICLES AND METHODS OF USE THEREOF | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2026-04-16 | — | — | US | claimed |
| EP-4714440-A2 | A HEALING HERBAL-MINERAL COMPOSITION WITH ENHANCED EFFECTS | Kurek, Janusz (PL) | 2026-03-25 | — | — | EP | claimed |
| EP-4698522-A1 | METHODS FOR PREPARING (-)-EPICATECHIN | Mars, Incorporated (US) | 2026-02-25 | — | — | EP | claimed |
| US-20260042741-A1 | METHODS FOR PREPARING (-)-EPICATECHIN | MARS, INCORPORATED (US) | 2026-02-12 | — | — | US | claimed |
| US-12533386-B2 | Preparation of black tea extract with high theaflavin content and use thereof | Jiangsu Dehe BBiological Technology Co., Ltd. (CN) | 2026-01-27 | — | — | US | claimed |
| EP-4678019-A1 | AN AEROSOL GENERATING MATERIAL | Nicoventures Trading Limited (GB) | 2026-01-14 | — | — | EP | claimed |
| JP-2004506656-A | — | — | 2004-03-04 | — | — | JP | claimed |
| WO-2003051287-A2 | TOPICAL COMPOSITIONS AND METHODS FOR TREATMENT OF ADVERSE EFFECTS OF IONIZING RADIATION | THE QUIGLEY CORPORATION (US) | 2003-06-26 | — | — | WO | claimed |
| WO-2003043628-A1 | MEDICAMENT FOR THE TREATMENT OF VIRAL SKIN AND TUMOUR DISEASES | MEDIGENE AKTIENGESELLSCHAFT (DE) | 2003-05-30 | — | — | WO | claimed |
| EP-1309333-A2 | PLANT-DERIVED AND SYNTHETIC PHENOLIC COMPOUNDS AND PLANT EXTRACTS, EFFECTIVE IN THE TREATMENT AND PREVENTION OF CHLAMYDIAL INFECTIONS | Control-Ox OY (FI) | 2003-05-14 | — | — | EP | claimed |
| WO-2002014464-A2 | PLANT-DERIVED AND SYNTHETIC PHENOLIC COMPOUNDS AND PLANT EXTRACTS, EFFECTIVE IN THE TREATMENT AND PREVENTION OF CHLAMYDIAL INFECTIONS | CONTROL-OX OY (FI) | 2002-02-21 | — | — | WO | claimed |
| EP-1089707-A1 | USE OF COSMETIC COMPOSITIONS CONTAINING CATECHINS OR GREEN TEA EXTRACT FOR SUN-TANNING | Beiersdorf Aktiengesellschaft (DE) | 2001-04-11 | — | — | EP | claimed |
| WO-1999066897-A1 | USE OF COSMETIC COMPOSITIONS CONTAINING CATECHINS OR GREEN TEA EXTRACT FOR SUN-TANNING | BEIERSDORF AG (DE) | 1999-12-29 | — | — | WO | claimed |
| EP-0789568-A4 | ANTINEOPLASTIC COCOA EXTRACTS, METHODS FOR MAKING, USING | MARS INC (US) | 1998-10-21 | — | — | EP | claimed |
| EP-0789568-A1 | ANTINEOPLASTIC COCOA EXTRACTS, METHODS FOR MAKING, USING | Mars Incorporated (US) | 1997-08-20 | — | — | EP | claimed |
| WO-1996010404-A1 | ANTINEOPLASTIC COCOA EXTRACTS, METHODS FOR MAKING, USING | MARS, INCORPORATED (US) | 1996-04-11 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260103663-A1 | ANTIMICROBIAL MATERIALS AND NANOPARTICLES AND METHODS OF USE THEREOF | DSTN, RHOA, FLOT1 | BACE1 1024/4885KDM4E 2051/4885HSD17B10 4198/4885 |
| US-20260042741-A1 | METHODS FOR PREPARING (-)-EPICATECHIN | CYP2E1, CYP1A1, ADH1A | BACE1 3406/4885KDM4E 418/4885HSD17B10 361/4885 |
| US-20260130395-A1 | Water Dispersible Botanical Compositions | TTPA, PNLIP, SRMS | BACE1 3685/4885KDM4E 4113/4885HSD17B10 2881/4885 |
| US-12533386-B2 | Preparation of black tea extract with high theaflavin content and use thereof | CAT, LPO, LIPC | BACE1 1836/4885KDM4E 1008/4885HSD17B10 493/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.